Dr Rob Weinkove (left) and David Downs

Scope 66 - David Downs: CAR T-cell recipient

30 July 2018, Cancer, CAR T-cell, Dr Robert Weinkove

Dr Rob Weinkove (left) and David Downs

David Downs, cancer survivor and self-declared ‘genetically modified organism’ recently visited the Malaghan Institute. Having successfully undergone CAR-T cell therapy in the USA, both David and the staff at the Institute were excited to meet and compare notes on our own CAR-T cell programme which is set to start trials in the near future.

During the visit, David made the generous pledge to raise $1 million towards the Institute’s CAR-T cell work to help give Kiwis better access to this breakthrough treatment.